Giant Med-Pharma Services

Giant Med-Pharma Services, also known as Jingcheng CRO, is a prominent Chinese contract research organization (CRO) founded in 2001. Headquartered in Beijing, it was among the first batch of CROs established in China and provides comprehensive research and development services for innovative drugs and medical devices. The company's expertise spans Phase I-IV clinical trials, regulatory affairs, data management, and quality control, with a track record of over 220 drug trials and 180 medical device studies. Notably, Giant Med-Pharma Services participated in the landmark CHANCE study published in the New England Journal of Medicine and maintains a significant presence in both traditional Chinese medicine and modern biopharmaceuticals.